1. StockCats12
2. ItsNewman
3. levawill000
4. 7998mom
5. wenday47
1.spottedgecko7 06/13/2018
Phase 3 data in the online Journal of the American Academy of Dermatology show Aclaris' ESKATA™ is safe and effective in treating persons with raised seborrheic keratoses
2.levawill000 02/08/2018
WOW! check out this PT
3.StockCats12 04/03/2018
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
4.StockCats12 12/01/2017
5 Biotech and Pharma Stocks with FDA Catalysts this December
5.ItsNewman 01/08/2018
Aclaris Therapeutics' A-101 45% Topical Solution Meets Primary and All Secondary Endpoints in Two Phase 2 Clinical Trials for Common Warts
6.7998mom 03/20/2018
Announces a publication in the Journal of Experimental Medicine
7.levawill000 03/10/2018
$ACRS in the news
8.levawill000 04/06/2018
Aclaris Therapeutics Partners with Cipher Pharmaceuticals to seek regulatory approval and commercialize A-101 40% topical solution for the treatment of raised seborrheic keratoses in Canada
9.ItsNewman 03/21/2018
Aclaris Therapeutics Announces ATI-450 (MK2 pathway Inhibitor) publication in Journal of Experimental Medicine
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW